Big Data Clinical Research Life Science Trials 
pharmaphorum
FEBRUARY 1, 2022
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?
Crucial Data Soutions
NOVEMBER 9, 2021
A paradigm shift is occurring in the clinical trials industry surrounding mobile technology, or more specifically, mobile health (mHealth) following the COVID-19 pandemic. Organizations are beginning to recognize the power mHealth has to positively affect their clinical trials and are implementing technologies at an increasing rate.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ACRP blog
APRIL 5, 2023
AI is increasingly important in drug discovery and development as well as clinical trials, operations, pharmacovigilance, and many other areas.” This has led to the emergence of a new ‘pharmaceutical intelligence’ that has allowed the industry to move away from traditional, slow-moving, and costly processes,” Lyons writes. “AI
Drug Discovery World
DECEMBER 20, 2022
As 2022 draws to a close, life sciences market analysts attempt to correctly predict what the next 12 months might bring to the drug discovery sector. There will be greater emphasis on diversity in clinical trials. DDW’s Diana Spencer summarises the key trends likely to impact the market in 2023. .
XTalks
MAY 9, 2024
XTALKS CLINICAL EDGE: Issue 2 — Genmab’s Interview Xtalks Clinical Edge is a magazine for clinical research professionals and all who want to be informed about the latest trends and happenings in clinical trials. Celebrating 25 years of innovation is a significant milestone.
Drug Discovery World
OCTOBER 12, 2022
DDW sits down with Mark Matson, Senior Solution Specialist for Sensor Cloud at Medidata, a Dassault Systèmes company, about the use of digital biomarkers in life sciences and how they can help advance our understanding of disease. . Companies are using sensors that we can put on our wrist or chest and capture all types of data.
pharmaphorum
MAY 25, 2021
Opportunities are growing for real-world evidence research as the technology matures and a pioneering new partnership between Savana, utilising its AI-driven clinical research methodology, and BREATHE aims to drive innovative research using this new way of working. The benefits of RWE. Patient-friendly studies.
Expert insights. Personalized for you.
104 
Let's personalize your content